Chiquita Brooks-LaSure (Photo by Caroline Brehman/CQ Roll Call via AP Images)
How CMS independence is at the forefront of its Alzheimer's drug coverage decision
Depending on who you ask, the Centers for Medicare and Medicaid Services’ (CMS) decision last week to restrict payment for amyloid-targeted Alzheimer’s drugs was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
